Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2024-10-05 Investor Presentation
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Updates
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation' and is explicitly described as such in the text. It includes business updates, financial highlights for Q1 FY25, company overview, key milestones, geographical presence, manufacturing facilities, and key customers. The document is submitted to the National Stock Exchange of India in compliance with SEBI Listing Regulations, indicating it is a formal investor communication. The content is typical of an investor presentation focusing on financials, strategy, and market position rather than a full annual or quarterly report, audit report, or earnings release. The length (15,000 characters) and detailed content support it being a full presentation rather than a brief announcement or regulatory filing. Therefore, the appropriate classification is 'Investor Presentation' (IP).
2024-10-05 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice from Ajooni Biotech Limited addressed to the National Stock Exchange of India. It informs about the closure of the trading window in compliance with SEBI regulations ahead of the announcement of un-audited financial results for the quarter and half year ended September 30, 2024. The document does not contain any financial data or results itself, nor does it present a report or detailed financial information. It is an announcement related to insider trading restrictions prior to financial results disclosure. Given the short length (1774 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than an Interim Report or Earnings Release. It is not a report publication announcement since it does not mention the report being attached or published, but rather a compliance notice about trading window closure.
2024-10-03 English
Change in Auditors
Regulatory Filings
2024-09-18 English
Shareholders meeting
Regulatory Filings
2024-09-18 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed communication regarding the outcome and proceedings of the 14th Annual General Meeting (AGM) of Ajooni Biotech Limited held on September 17, 2024. It includes information about the business transacted at the AGM, such as adoption of audited financial statements, re-appointment of a director, appointment of auditors, and approval of related party transactions. It also describes the voting process and mentions the appointment of a scrutinizer for e-voting. The document is addressed to the stock exchange and is clearly an official announcement of the AGM results and proceedings rather than the full AGM presentation materials or the annual report itself. The length (7923 characters) and content indicate it is not a brief notice but a comprehensive summary of the AGM outcome. Therefore, the document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-09-17 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Ajooni Biotech Limited has received BIS certification and ISI Mark for its mineral mixture product. It includes a statement from the MD & CFO, some financial highlights for FY 2023-24, and projections for FY 2024-25. The document is short (3386 characters) and primarily focuses on a certification achievement and business outlook rather than detailed financial statements or comprehensive report content. There is no indication that this is a full annual report, audit report, or earnings release. It is also not a regulatory filing or certification letter. The content is an announcement of a certification achievement and business update, which fits best under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2024-09-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.